Related references
Note: Only part of the references are listed.Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M trial): A double-blind placebo-controlled randomised trial
Charlotte Hamel et al.
ECLINICALMEDICINE (2021)
Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial
Sarita Sonalkar et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2020)
Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss
Courtney A. Schreiber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Early Pregnancy Loss
Sarah Prager et al.
OBSTETRICS AND GYNECOLOGY (2018)
Serum human chorionic gonadotropin (hCG) trend within the first few days after medical abortion: a prospective study
Katherine D. Pocius et al.
CONTRACEPTION (2017)
Utility of βhCG monitoring in the follow-up of medical management of miscarriage
Scott G. Petersen et al.
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2017)
Serial multilevel urine pregnancy testing to assess medical abortion outcome: a meta-analysis
Elizabeth G. Raymond et al.
CONTRACEPTION (2017)
RU OK? The acceptability and feasibility of remote technologies for follow-up after early medical abortion
Hillary Bracken et al.
CONTRACEPTION (2014)
Medication abortion employing routine sequential measurements of serum hCG and sonography only when indicated
Wesley Clark et al.
CONTRACEPTION (2007)
Hormone pattern after misoprostol administration for a nonviable first-trimester gestation
KT Barnhart et al.
FERTILITY AND STERILITY (2004)
Decline of serum human chorionic gonadotropin and spontaneous complete abortion: Defining the normal curve
K Barnhart et al.
OBSTETRICS AND GYNECOLOGY (2004)